RECURRENT CANCER
Clinical trials for RECURRENT CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune drug aims to tackle tough cancers
Disease control OngoingThis early-stage trial tests a new drug called IMA401, alone or with the immunotherapy Keytruda, in adults with advanced solid tumors that have come back or not responded to treatment. The study includes about 95 people whose tumors have specific markers (MAGE-A4 or MAGE-A8) and …
Matched conditions: RECURRENT CANCER
Phase: PHASE1 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
New drug shows promise for Hard-to-Treat ovarian cancer
Disease control OngoingThis study tests a new drug called CYH33 for women whose ovarian, fallopian tube, or peritoneal clear cell cancer has come back or not gone away. The drug targets a specific gene change (PIK3CA mutation) to try to shrink tumors. About 93 women who have already tried standard chem…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
Nanoparticle-Proton combo for recurrent tumors: study pulled
Disease control TerminatedThis study aimed to test a new treatment for people whose cancer returned in an area already treated with radiation. The approach combined special nanoparticles injected into the blood with proton therapy to target tumors in the head, spine, or pelvis. The goal was to see if this…
Matched conditions: RECURRENT CANCER
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC